Open archive
Clear filters
Showing 1-24 of 83 published briefings.
Sector archive
Published briefings for one sector.
Browse recent results from companies in the same sector.
Rua Bioscience (RUA)FY26Released 28 August 2026
Revenue rose 93.5% while borrowings climbed 55.9%
Revenue reached $2.9m and cash rose to $0.534m, but operating cash outflow widened to $3.0m.
Published 29 August 2026
Read briefingSummerset Group Holdings (SUM)HY26Released 27 August 2026
Underlying profit fell 3% while statutory PBT jumped 63.1%
Debtor days rose to 105.6 while underlying profit fell 3%, masking the drivers behind a 63.1% jump in statutory profit before tax.
Published 27 August 2026
Read briefingEBOS Group (EBO)FY26Released 19 August 2026
Cash conversion fell to 58.3% while tax relief lifted NPAT, PBT down 1.0%
Revenue rose 9.9% and NPAT rose 4.7%, but PBT fell 1.0% and operating cash conversion dropped to 58.3% from 75.3%.
Published 19 August 2026
Read briefingPacific Edge (PEB)FY26Released 25 June 2026
Revenue nearly halved as losses and cash burn both deepened
Revenue fell 47.4% on lost Medicare coverage while operating cash outflow widened 29.1%, deepening cash pressure.
Published 19 August 2026
Read briefingThird Age Health Services (TAH)FY26Released 29 May 2026
PBT up 25.7% on ARC scale, full-year dividend reset to 8.0c
Aged-care consolidation lifted earnings and revenue mix, but a halved dividend and weaker cash conversion signal a clear reinvestment pivot.
Published 29 May 2026
Read briefingTruscreen Group (TRU)FY26Released 29 May 2026
Revenue up 42% but missed $2.8m guidance as debtors swelled to $1.0m
A 140bps gross margin lift is real, but a $1.0m receivables build and ongoing $2.5m operating cash burn keep the runway question open.
Published 29 May 2026
Read briefingGreen Cross Health (GXH)FY26Released 29 May 2026
Medical services-led NPAT growth of 27.5% on 4.2% revenue lift
The earnings step-up was concentrated in the smaller Medical services segment while operating cash flow grew only 3.7% and free cash flow fell.
Published 29 May 2026
Read briefingPromisia Healthcare (PHL)FY26Released 28 May 2026
FY26 NPAT $12.9m hinges on H2 swing; EBITDAF $6.6m the cleaner read
Full-year Cromwell consolidation and a sharp H2 earnings swing lift reported NPAT while net debt/EBITDAF falls to 5.8x.
Published 28 May 2026
Read briefingRyman Healthcare (RYM)FY26Released 26 May 2026
Free cash flow swings to +NZ$188m as EBITDAF nearly doubles
Operating momentum is real but Ryman remains loss-making at the PBT line, and the FCF swing is partly capex-driven rather than purely earnings-led.
Published 26 May 2026
Read briefingFisher & Paykel Healthcare (FPH)FY26Released 26 May 2026
FPH capex nearly doubled to NZ$195.2m, compressing FCF conversion
Operating cash flow rose to NZ$663.2m and cash built to NZ$461.1m, but capex hit 8.5% of revenue and FCF/NPAT fell to 95.3%.
Published 26 May 2026
Read briefingBLIS Technologies (BLT)FY26Released 21 May 2026
Revenue up 16% but working-capital absorption turned operating cash flow
A NZ$1.8m working-capital build—versus a historical average release of NZ$0.2m—consumed all reported profit and then some, turning free cash flow
Published 21 May 2026
Read briefingRadius Residential Care (RAD)FY26Released 13 May 2026
PBT up 36.2% and cash conversion at 91.8% as capex more than doubled
Underlying earnings ran above the historical baseline, but H2 NPAT roughly halved versus H1 as growth-strategy capex stepped up to NZ$16.1m.
Published 19 May 2026
Read briefingRua Bioscience (RUA)HY26Released 27 February 2026
Revenue grew to NZ$1.3m but losses persisted as borrowings quadrupled
A 4.5x step-up in debt funded most of the cash uplift while total assets sit below the supplied historical range.
Published 22 May 2026
Read briefingSummerset Group Holdings (SUM)FY25Released 27 February 2026
PBT fell 32.2% on smaller revaluation gains; underlying profit up 13%
IFRS earnings dropped on lower investment property fair-value uplifts, masking a 26% jump in unit settlements and 23.7% rise in operating cash flow.
Published 21 April 2026
Read briefingEBOS Group (EBO)HY26Released 25 February 2026
Cash conversion collapsed to 15.4% as working capital absorbed $348m
Revenue grew 13.0% and FY26 EBITDA guidance was reaffirmed, but operating cash flow fell to $46.6m and the dividend was not covered by free cash flow.
Published 21 April 2026
Read briefingGreen Cross Health (GXH)HY26Released 28 November 2025
NPAT grew 28.6% but pre-lease FCF fell to NZ$15.6m, a 3-year low
Working capital absorption and a near-tripling of capex weakened cash conversion even as reported earnings grew above the historical range.
Published 22 April 2026
Read briefingBLIS Technologies (BLT)HY26Released 27 November 2025
Revenue grew 28.1% but operating cash swung negative on inventory build
A $1.4m working-capital absorption pushed HY26 operating cash flow to -$0.5m, contradicting the $0.5m EBITDA and PBT-doubling headline.
Published 22 April 2026
Read briefingRyman Healthcare (RYM)HY26Released 27 November 2025
PBT collapsed 123% to a NZ$40.2m loss as debt fell NZ$928m
Maiden NZ$56.2m FCF and the balance sheet reset frame the upside, but a NZ$152.7m receivables release flatters the cash result.
Published 21 April 2026
Read briefingFisher & Paykel Healthcare (FPH)HY26Released 26 November 2025
FPH PBT margin reached 26.1%, lifting profit 37.5% on 14.4% revenue growth
Operating leverage pushed margins above the recent historical range even as FCF conversion eased from 110.6% to 81.3% of NPAT.
Published 21 April 2026
Read briefingPacific Edge (PEB)HY26Released 25 November 2025
Revenue down 45.8% as Medicare coverage loss halves US diagnostic income
Pacific Edge's HY26 operating loss widened to NZ$19.1M after Medicare coverage was withdrawn, with just NZ$15.1M cash remaining to fund an ongoing
Published 18 May 2026
Read briefingOceania Healthcare (OCA)HY26Released 21 November 2025
OCA swung to PBT positive but capex jumped 82% to 40.4% of revenue
EBITDA rose 7.4% on flat revenue and PBT turned positive at $1.0m, but a doubled investment cycle kept free cash flow at -$8.4m.
Published 21 April 2026
Read briefingRadius Residential Care (RAD)HY26Released 19 November 2025
PBT up 204% on 19% revenue growth as cash conversion lifted to 89%
A lower effective tax rate flattered NPAT, but EBITDA +41% and leverage cut to 4.3x point to genuine operating gains.
Published 23 April 2026
Read briefingRua Bioscience (RUA)FY25Released 1 September 2025
RUA revenue rose 490.6% but the business remains deeply cash-negative
Strong commercial momentum cut the loss before tax by 74.8%, yet cash fell to NZD 0.2m and operating outflows persist, making runway the central
Published 19 May 2026
Read briefingSummerset Group Holdings (SUM)HY25Released 28 August 2025
Underlying profit +19% on 692 sales, but NPAT flattered by tax swing
OCF rose 19.3% to $228.7m and gross borrowings grew 21.3% to $1.87b as $311.6m of development capex left free cash flow at -$17.7m.
Published 23 April 2026
Read briefingGet reporting-season briefings
Get full NZX result briefings by email as new coverage is published.